Durham, North Carolina, March 26, 2008 – Vascular BioSciences announced today it has been awarded a $100,000 STTR matching grant under the One North Carolina SBIR/STTR Matching Funds Program. The One North Carolina SBIR/STTR Matching Grant matches a recently awarded NIH Phase 1 STTR grant “Targeting Pulmonary Hypertension with R-Ras.”
David Mann, CEO of Vascular BioSciences commented, “This matching grant from the State of North Carolina will enable our company to expand our innovative product pipeline and to accelerate our commercialization efforts. I’d like to especially acknowledge the assistance and support of Governor Mike Easley, Congressman David Price, State Senator Floyd McKissick, Jr., State Representative Henry Michaux, Jr., the North Carolina Office of Science and Technology, and the North Carolina Department of Commerce.”
About Vascular BioSciences
Vascular BioSciences, a diversified biomedical company based in Research Triangle, North Carolina, provides solutions for vascular–based diseases in order to enhance and prolong human life.
Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides diagnostic services, and advances therapies in order to improve outcomes for vascular–based disease patients.